[HTML][HTML] Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma

SK Gautam, SK Batra, M Jain - Molecular cancer, 2023 - Springer
Immunosuppression is a hallmark of pancreatic ductal adenocarcinoma (PDAC),
contributing to early metastasis and poor patient survival. Compared to the localized tumors …

[HTML][HTML] The Synergistic Cooperation between TGF-β and hypoxia in Cancer and fibrosis

P Mallikarjuna, Y Zhou, M Landström - Biomolecules, 2022 - mdpi.com
Transforming growth factor β (TGF-β) is a multifunctional cytokine regulating homeostasis
and immune responses in adult animals and humans. Aberrant and overactive TGF-β …

Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers

H Zhang, K Cao, J Xiang, M Zhang, M Zhu, Q Xi - Cancer Letters, 2023 - Elsevier
Pancreatic cancer is one of the common malignant tumors of the digestive system and is
known as the “king of cancers”. It is extremely difficult to diagnose at an early stage, the …

[HTML][HTML] Epigenetic reprogramming-induced guanidinoacetic acid synthesis promotes pancreatic cancer metastasis and transcription-activating histone modifications

J Yang, B Ren, J Ren, G Yang, Y Fang, X Wang… - Journal of Experimental …, 2023 - Springer
Background Pancreatic ductal adenocarcinoma (PDAC) tends to undergo distant
metastasis, especially liver metastasis, leading to a poor prognosis. Metabolic remodelling …

Pharmacological inhibition of KDM5A for cancer treatment

GJ Yang, J Wu, L Miao, MH Zhu, QJ Zhou, XJ Lu… - European Journal of …, 2021 - Elsevier
Lysine-specific demethylase 5A (KDM5A, also named RBP2 or JARID1A) is a demethylase
that can remove methyl groups from histones H3K4me1/2/3. It is aberrantly expressed in …

[HTML][HTML] An eight-gene hypoxia signature predicts survival in pancreatic cancer and is associated with an immunosuppressed tumor microenvironment

R Abou Khouzam, SP Rao, GH Venkatesh… - Frontiers in …, 2021 - frontiersin.org
Intratumoral hypoxia is a widely established element of the pancreatic tumor
microenvironment (TME) promoting immune escape, tumor invasion, and progression, while …

[HTML][HTML] NADPH oxidase 4: a potential therapeutic target of malignancy

S Gong, S Wang, M Shao - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
Reactive oxygen species (ROS) play a crucial role in the regulation of tumor occurrence and
development. As a main source of ROS, NADPH oxidases are key enzymes that mediate …

Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular

O Li, L Li, Y Sheng, K Ke, J Wu, Y Mou, M Liu, W Jin - Cancer Letters, 2023 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a highly life-threatening tumour with a low
early-detection rate, rapid progression and a tendency to develop resistance to …

[HTML][HTML] NOX4: a potential therapeutic target for pancreatic cancer and its mechanism

Y Bi, X Lei, N Chai, E Linghu - Journal of translational medicine, 2021 - Springer
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) is one of the
seven isoforms of NOX family, which is upregulated in pancreatic cancer cell, mouse model …

[HTML][HTML] Cellular and exosomal GPx1 are essential for controlling hydrogen peroxide balance and alleviating oxidative stress in hypoxic glioblastoma

FJ Lei, JY Chiang, HJ Chang, DC Chen, HL Wang… - Redox Biology, 2023 - Elsevier
Tumor hypoxia promotes malignant progression and therapeutic resistance in glioblastoma
partly by increasing the production of hydrogen peroxide (H 2 O 2), a type of reactive oxygen …